Can cell and gene therapies improve cognitive symptoms in Parkinson’s disease? by Mariah J. Lelos

Get full text

Defining the unknowns for cell therapies in Parkinson's disease by Emma L. Lane, Mariah J. Lelos

Get full text

Impaired cognitive and motor function are coincident with l-DOPA-induced dyskinesia in a model of Parkinson’s disease by Mariah J. Lelos, Ellen M. Murphy, Hanna S. Lindgren, Stephen B. Dunnett, Emma L. Lane

Get full text

Direct Comparison of Rat- and Human-Derived Ganglionic Eminence Tissue Grafts on Motor Function by Mariah J. Lelos, Victoria H. Roberton, Ngoc-Nga Vinh, Carl Harrison, Peter Eriksen, Eduardo M. Torres, Susanne P. Clinch, Anne E. Rosser, Stephen B. Dunnett

Get full text

Inhibition of 7α,26-dihydroxycholesterol biosynthesis promotes midbrain dopaminergic neuron development by James Hennegan, Aled H. Bryant, Lauren Griffiths, Matthieu Trigano, Oliver J.M. Bartley, Joanna J. Bartlett, Carys Minahan, Willy Antoni Abreu de Oliveira, Eylan Yutuc, Sotirios Ntikas, Christos S. Bartsocas, Margarita Markouri, Eleni Antoniadou, Ioanna Laina, Owain W. Howell, Meng Li, Yuqin Wang, William J. Griffiths, Emma L. Lane, Mariah J. Lelos, Spyridon Theofilopoulos

Get full text

Nuclear ERK1/2 signaling potentiation enhances neuroprotection and cognition via Importinα1/KPNA2 by Marzia Indrigo, Ilaria Morella, Daniel Orellana, Raffaele d'Isa, Alessandro Papale, Riccardo Parra, Antonia Gurgone, Daniela Lecca, Anna Cavaccini, Cezar M Tigaret, Alfredo Cagnotto, Kimberley Jones, Simon Brooks, Gian Michele Ratto, Nicholas D Allen, Mariah J Lelos, Silvia Middei, Maurizio Giustetto, Anna R Carta, Raffaella Tonini, Mario Salmona, Jeremy Hall, Kerrie Thomas, Riccardo Brambilla, Stefania Fasano

Get full text